VEGF Expression in Melanoma
Author Information
Author(s): P Salven, P Heikkila, H Joensuu
Primary Institution: Helsinki University Central Hospital
Hypothesis
The study investigates the expression of VEGF in normal dermis, naevocellular naevi, and in primary and metastatic melanoma.
Conclusion
VEGF is up-regulated during melanoma progression and may contribute to the disease's progression.
Supporting Evidence
- VEGF was detected in 91% of melanoma metastases but only 32% of primary melanomas.
- A high number of VEGF-expressing inflammatory cells was associated with high VEGF expression in melanoma cells.
- VEGF expression was not associated with overall survival in the studied patient population.
Takeaway
This study found that a protein called VEGF is more common in advanced melanoma than in early stages, which might help the cancer grow.
Methodology
The study used immunohistochemistry to assess VEGF expression in tissue samples from melanoma patients.
Limitations
The study's findings may not be generalizable beyond the specific patient population studied.
Participant Demographics
The study included 55 patients with malignant melanoma, 20 males and 13 females, aged 30 to 84 years.
Statistical Information
P-Value
p<0.0001; p=0.003
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website